We are live on ! Find out more
SOPH icon

SOPHiA GENETICS

32 hedge funds and large institutions have $43.2M invested in SOPHiA GENETICS in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

1.78% less ownership

Funds ownership: 27.82%26.05% (-1.8%)

6% less funds holding

Funds holding: 3432 (-2)

10% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 10

46% less capital invested

Capital invested by funds: $80.2M → $43.2M (-$37M)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
32
Holders Change
-2
Holders Change %
-5.88%
% of All Funds
0.51%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
2
Increased
9
Reduced
10
Closed
4
Calls
Puts
Net Calls
Net Calls Change

SOPH Hedge Fund Activity: Q3 2023 in Review

32 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in SOPHiA GENETICS (SOPH) for Q3 2023, worth a combined $43.2M — down 46% from $80.2M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of SOPH and 2 opened new positions — a net loss of 2 holders — while 10 trimmed existing stakes and 9 added.

The largest buyer was Millennium Management, adding an estimated $998K. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $4.29M sold.

  • 32 institutional investors held SOPHiA GENETICS (SOPH) as of Q3 2023, down from 34 in Q2 2023.
  • Funds reported $43.2M of SOPHiA GENETICS stock for Q3 2023, down 46% quarter-over-quarter.
  • 2 funds opened new SOPHiA GENETICS positions in Q3 2023 and 4 closed out, a net change of -2 holders.
  • The largest SOPHiA GENETICS buyer in Q3 2023 was Millennium Management, an estimated $998K added.
  • The largest SOPHiA GENETICS seller in Q3 2023 was T. Rowe Price Associates, an estimated $4.29M sold.

Based on aggregated 13F filings for Q3 2023.